Report ID: 10077079 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Cardiopulmonary Exercise Testing Market Highlights Over 2022- 2031
The global cardiopulmonary exercise testing market is estimated to grow at a ~5% CAGR over the forecast period, i.e., 2022–2031. Moreover, the market registered a revenue of approximately USD 3.0 billion in 2021. The growth of the market can be attributed to the surge in the volume of subsidies provided by the government of nations for the advancement of healthcare infrastructure and the rise in research and development activities for developing cardiovascular exercise testing devices to detect the disease at an earlier stage. Moreover, an increase in the number of heart disease cases across the globe is anticipated to drive the growth of the market. As per the World Health Organization, approximately 17.9 million people died in 2019 from cardiovascular disease which accounted to 32 percent of global deaths.
GET A SAMPLE COPY OF THIS REPORT
The global cardiopulmonary exercise testing market is segmented by end-user into clinics & hospitals, ambulatory centers, and diagnostic centers. Out of these, the clinics & hospitals segment is anticipated to hold the largest share by the end of 2031 owing to the rise in the number of patients arriving for treatment in the hospital and its high financial capability to keep updated technology for the diagnosis of the patient.
Global Cardiopulmonary Exercise Testing Market Regional Synopsis
Regionally, the global cardiopulmonary exercise testing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the North America region is estimated to witness noteworthy growth over the forecast period on the back of an increase in the number of heart disease cases, and rising awareness among people related to the cardiopulmonary exercise testing system for diagnosis of the disease. According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the U.S and accounts for a death of a person in every 36 seconds.
Market Segmentation
Our in-depth analysis of the global cardiopulmonary exercise testing market includes the following segments:
By End-User
-
Clinics & Hospitals
-
Ambulatory Centers
-
Diagnostic Centers
By Product Type
-
Stress Blood Pressure Monitors
-
Exercise Testing Systems
-
Pulse Oximeters
-
Others
Growth Drivers and Challenges Impacting the Growth of the Global Cardiopulmonary Exercise Testing Market
Growth Drivers
-
Increasing R&D Activities for the Development of Advanced Cardiopulmonary Exercise Testing Products
-
Growing Number of Heart Disease Cases Across the Globe
Challenges
-
High Cost of the Cardiopulmonary Exercise Testing Devices
-
Lack of Skilled Workers for Operating these Devices
Key Companies Dominating the Global Cardiopulmonary Exercise Testing Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global cardiopulmonary exercise testing market that are included in our report are NIHON KOHDEN CORPORATION, MGC Diagnostics Corporation, VYAIRE MEDICAL, INC., Koninklijke Philips N.V., Schiller Americas, Inc., General Electric Company, COSMED srl, Therma Fisher Scientific, Halma plc, Masimo, and others.
Latest Developments in the Global Cardiopulmonary Exercise Testing Market:
- 21 December 2021 – General Electric Company announced the acquisition of BK Medical from Altaris Capital Partners, LLC has been completed. The companies agreed to a definitive agreement in which GE will buy BK Medical for USD 1.45 billion in cash.
- 8 December 2021: Thermo Fisher Scientific Inc., announced the completion of its USD 17.4 billion acquisition of PPD, Inc. in order to expand their value proposition for biotech and pharmaceutical customers.
Key Reasons to Buy Our Report
- The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
- It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
- The report includes detailed company profiles of the major players dominating the market.
- We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
- We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Frequently Asked Question
The global cardiopulmonary exercise testing market is segmented by product type, end-user, and by region.
The clinics & hospitals segment is anticipated to hold largest share over the forecast period and display significant growth opportunities.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10077079 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
